PSI Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-52
Closed -$22.6K 259
2025
Q1
$22.6K Hold
52
0.01% 357
2024
Q4
$19.2K Hold
52
0.01% 426
2024
Q3
$27K Buy
+52
New +$27.8K 0.01% 368
2024
Q2
Sell
-42
Closed -$21.8K 882
2024
Q1
$21.8K Hold
42
0.01% 384
2023
Q4
$19.8K Hold
42
0.01% 418
2023
Q3
$18.3K Buy
42
+7
+20% +$3.17K 0.01% 405
2023
Q2
$15.6K Hold
35
0.01% 426
2023
Q1
$16.1K Hold
35
0.01% 368
2022
Q4
$18K Sell
35
-295
-89% -$150K 0.01% 336
2022
Q3
$150K Hold
330
0.08% 134
2022
Q2
$159K Hold
330
0.08% 137
2022
Q1
$162K Hold
330
0.07% 149
2021
Q4
$153K Hold
330
0.06% 164
2021
Q3
$123K Buy
+330
New +$125K 0.06% 180

Other funds holding ELV

PSI Advisors's ELV Position: Q2 2025 in Review

PSI Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 52 shares — an estimated $22.6K sold.

PSI Advisors first reported a position in ELV in Q3 2021 and held it in 14 quarters. The position peaked at $162K in Q1 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • PSI Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • PSI Advisors sold 52 Elevance Health shares in Q2 2025, an estimated $22.6K.
  • PSI Advisors first reported a position in Elevance Health in Q3 2021 and held it in 14 quarters.
  • PSI Advisors's Elevance Health position peaked at $162K in Q1 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.